BioSpace News Archive

Policy

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PolarityTE, Inc. (COOL)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PolarityTE, Inc.

June 25, 2018
·
1 min read
Genetown

Streamline Review of EudraVigilance Data with Commonwealth Vigilance Workbench (CVW) - Investigate

Commonwealth Informatics announced CVW Investigate, a cloud-based software service that helps customers successfully meet European requirements to monitor the safety of their products using data from the EudraVigilance Data Analysis System in the form of electronic Reaction Monitoring Reports (eRMRs).

June 25, 2018
·
2 min read
Drug Development

New Imeglimin Data Demonstrating Pancreatic Beta-Cell Protection Presented at the American Diabetes Association 78th Scientific Sessions

Imeglimin was observed to protect and preserve human beta-cells from cell death from fructose- and glucose-induced toxicity by inhibiting mitochondrial Permeability Transition Pore opening

June 25, 2018
·
6 min read
Policy

US Patent & Trademark Office Issues New Patent to DenMat for Removable Dental Appliances, Branded Snap-On Smile®

Results in an improved smile without any need to alter the structure of a patient’s existing dentition.

June 25, 2018
·
2 min read
Business

AbbVie and Calibr announce collaboration for next generation T-cell therapies

Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors

June 25, 2018
·
4 min read
Drug Development

Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer

Results show a positive trend in the secondary endpoint of overall survival, though not reaching statistical significance

June 25, 2018
·
11 min read
Business

Synthetic Genomics Appoints Reinhard J. Ambros, Ph.D., Former Global Head of the Novartis Venture Fund to Board of Directors

Dr. Ambros was the global head of the Novartis Venture Fund from 2005 to 2017 and built one of the largest and most active corporate Biotechnology Venture Funds globally.

June 25, 2018
·
3 min read
Drug Development

Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer

A single administration of topsalysin continues to demonstrate an ability to ablate targeted prostate cancer cells with 10 of 35 patients (29%) demonstrating a clinical response of which 6 patients had a complete ablation with no detectable cancer on targeted biopsy of the treated area.

June 25, 2018
·
12 min read
Drug Development

Xeris Pharmaceuticals Announces Positive Phase 3 Clinical Trial Data on Its Investigational Ready-to-Use Glucagon Rescue Pen

Results of two Phase 3 studies presented at the American Diabetes Association’s 78th Scientific Sessions

June 25, 2018
·
6 min read
Deals

Senseonics Announces Public Offering of Common Stock

Senseonics Holdings, Inc. announced that it has commenced a registered underwritten public offering of $80 million of its shares of common stock.

June 25, 2018
·
2 min read